HIGHLIGHTS
- who: RAPGEF and colleagues from the The Affiliated Hospital of Qingdao University, Department of Anesthesiology, Qingdao, Shandong, China have published the paper: Genetics and Molecular Biology, in the Journal: (JOURNAL)
- what: We demonstrated that dezocine treatment combined with overexpression of RAPGEF3 significantly increased the viability of cells, decreased the expression of inflammation-related cytokines at the transcriptional level and the concentration of inflammatory cytokines in cultured medium and serum samples of cells and rats.
- how: The results showed that dezocine increased the viability rate of cells and overexpression of RAPGEF3 enhanced this effect . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.